IMULDOSA 130 mg / 26 ml conc perf 130 mg 1 pce

7680702250014 CH-70225 L04AC05 07.15.0.

Active substances:

Ustekinumabum

No images available

Details

Product number
7022501
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
ustekinumabum 130 mg, saccharum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, methioninum, dinatrii edetas, aqua ad iniectabile q.s. ad solutionem pro 26 ml, natrium 0.06 mg.

Articles (1)

Imuldosa 130 mg / 26 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
ustekinumabum
130.0 MG Substance Wirkstoff (Principe actif)
saccharum
- Substance HNIDK
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
methioninum
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.06 MG Substance HBESI

Reimbursement information

Public price
CHF 1252.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2026

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
70225
Drug name
Imuldosa, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
L04AC05
Authorization status
Z
Dispensation category
B
First authorization
14/11/2025
Authorization expiration date
13/11/2030
IT number
07.15.0.
Domain
Human medicine
Field of application
Morbus Crohn, Ulcerative Colitis

Packaging details

Description (FR)
IMULDOSA 130 mg / 26 ml conc perf 130 mg 1 pce
Description (DE)
IMULDOSA 130 mg / 26 ml Konz Inf 130 mg 1 Stk
Market launch
29/04/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data